Skip to main content

Advertisement

SpringerLink
Log in

The role of tramadol in cancer pain treatment—a review

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

In most cancer patients pain can be successfully treated with pharmacological measures using opioid analgesics alone or in combination with adjuvant analgesics (coanalgesics). Weak opioids are usually recommended in the treatment of moderate cancer pain. There is still a debate as to whether the second step of the WHO analgesic ladder comprising opioid analgesics such as tramadol, codeine, dihydrocodeine, and dextropropoxyphene is still needed for the treatment of cancer pain. On the basis of our experience and review of the literature we think that there is definitely a place for weak opioids in the treatment of moderate cancer pain. One of the most interesting and useful weak opioids is tramadol (Adolonta, Contramal, Nobligan, Top-Algic, Tramal, Tramal Long, Tramal Retard, Tramundin, Trodon, Ultram, Zydol). Its unique mechanism of action, analgesic efficacy and profile of adverse reactions have been the reason of performing many experimental and clinical studies with tramadol. In this article we summarize data on pharmacology, mechanisms of action, pharmacokinetics, side effects and clinical experience assessing analgesic efficacy, adverse reactions and safety of tramadol in cancer pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Arcioni R, Rocca DM, Romano S, Romano R, Pietropaoli P, Gasparetto A (2002) Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT(3) spinal receptor involvement in acute pain in humans. Anesth Analg 94(6):1533–1577

    Google Scholar 

  2. Baraka A, Jabbour S, Nader A, et al (1993) A comparison of epidural tramadol and epidural morphine for postoperative analgesia. Can J Anaesth 40(4):308–313

    CAS  PubMed  Google Scholar 

  3. Barnung SK, Treschow M, Borgbjerg FM (1997) Respiratory depression following oral tramadol in a patient with impaired renal function, Pain 71:111–112

    Google Scholar 

  4. Barth H, Durra S, Giertz H, Goroll D, Flohé L (1987) Long-term administration of the centrally acting analgesic tramadol did not induce dependence or tolerance. Pain [Suppl] 4:S231

  5. Bianchi M, Rossoni G, Sacerdote P, Panerai AE (1999) Effects of tramadol on experimental inflammation. Fundam Clin Pharmacol 13:220–225

    CAS  PubMed  Google Scholar 

  6. Bodalia B, McDonald CJ, Smith KJ, O’Brien C, Cousens L (2003) A comparison of the pharmacokinetics, clinical efficacy, and tolerability of once-daily tramadol tablets with normal release tramadol capsules. J Pain Symptom Manage 25:142–149

    Article  CAS  PubMed  Google Scholar 

  7. Bono AV, Cuffari S (1997) Effectiveness and tolerance of tramadol in cancer pain. A comparative study with respect to buprenorphine (in French). Drugs 53 [Suppl 2]:40–49

  8. Brema F, Pastorino G, Martini MC, et al (1996) Oral tramadol and buprenorphine in tumour pain. An Italian multicenter trial. Int J Clin Pharm Res 16(4-5):109–116

    Google Scholar 

  9. Cicero JC, Adams EH, Geller A, Inciardi JA, Munoz A, Schnoll SH, Senay EC, Woody GE (1999) A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend 57:7–22

    Article  CAS  PubMed  Google Scholar 

  10. Collart L, Luthy C, Dayer P (1993) Partial inhibition of tramadol antinociceptive effect by naloxone in man (abstract). Br J Clin Pharmacol 35:73P

    Google Scholar 

  11. Cossmann M, Wilsmann KM (1987) Effect and side-effects of tramadol. Therapiewoche 37:3475–3485

    Google Scholar 

  12. Cossmann M, Kohnen C, Langford R, McCartney C (1997) Tolérance et sécurité d’emploi du tramadol. Résultats des études internationales et données de la pharmacovigilance, Drugs 53 [Suppl 2]:50–62

  13. Delikan AE, Vijayan R (1993) Epidural tramadol for postoperative pain relief. Anaesthesia 48:328–331

    PubMed  Google Scholar 

  14. Duggan AK (1995) The cost of constipation in morphine patients and the economic possibilities with tramadol. Br J Med Econ 9:21–29

    Google Scholar 

  15. Edwards JE, McQuay HJ, Moore RA (2002) Combination analgesic efficacy: individual patient data meta-analysis of single-dose oral tramadol plus acetaminophen in acute postoperative pain. J Pain Symptom Manage 23:121–130

    Article  CAS  PubMed  Google Scholar 

  16. Friderichs E, Reimann W, Selve N (1992) Contribution of both enantiomers to antinociception of the centrally acting analgesic tramadol (abstract P82). Naunyn Schmiedebergs Arch Pharmacol 346 [Suppl 1]:R36

  17. Gasse CBS, Derby L, Vasilakis-Scaramozza C, Jick H (2000) Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy 20(6):629–634

    Article  CAS  PubMed  Google Scholar 

  18. Gillen G, Haurand M, Kobelt DJ, Wnendt S (2000) Affinity, potency and efficacy of tramadol and its metabolites at the cloned human μ-opioid receptor, Naunyn Schmiedebergs Arch Pharmacol 362:116–121

    Google Scholar 

  19. Grond S, Radbruch L, Meuser T, et al (1999) High-dose tramadol in comparison to low-dose morphine for cancer pain. J Pain Symptom Manage 18:174–179

    Article  CAS  PubMed  Google Scholar 

  20. Grond S, Zech D, Lynch J, et al (1992) Tramadol—a weak opioid for relief of cancer pain. Pain Clinic 5(4):241–247

    Google Scholar 

  21. Hennies MH, Friderichs E, Schneider J (1988) Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung 38:877–880

    CAS  PubMed  Google Scholar 

  22. Hopkins D, Shipton EA, Potgieter D, Van Der Merve CA, Boon J, De Wet C, Murphy J (1998) Comparison of tramadol and morphine via subcutaneous PCA following major orthopaedic surgery, Can J Anaesth 45:435–442

    Google Scholar 

  23. Houmes RJM, Voets MA, Verkaaik A, et al (1992) Efficacy and safety of tramadol versus morphine for moderate and severe postoperative pain with special regard to respiratory depression. Anesth Analg 74:510–514

    CAS  PubMed  Google Scholar 

  24. Husslein P, Kubista E, Egarter C (1987) Obstetric analgesia with tramadol—results of a prospective randomised comparison with pethidine. Z Geburtshilfe Perinatol 191(6):234–237

    CAS  PubMed  Google Scholar 

  25. Klotz U, Fischer-Bosch M (2003) Tramadol—the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of pain. Arzneimittelforschung 53(10):681–687

    CAS  PubMed  Google Scholar 

  26. Kupers R, Callebaut V, Debois V, et al (1995) Efficacy and safety of oral tramadol and pentazocine for postoperative pain following prolapsed intervertebral disc repair. Acta Anaesth Belg 46:31–37

    CAS  PubMed  Google Scholar 

  27. Lee CR, McTavish D, Sorkin EM (1993) Tramadol—a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs 46(2):313–340

    CAS  PubMed  Google Scholar 

  28. Lenzhofer R, Moser K (1984) Analgesic effect of tramadol in patients with malignant diseases. Wien Med Wochenschr 134(8):199–202

    CAS  PubMed  Google Scholar 

  29. Leppert W (2000) Assessment of analgesic efficacy and side-effects of tramadol and morphine administered orally in the treatment of cancer pain. Basic and Advanced Palliative Medicine Course. Puszczykowo, Poznań, 14–19 May 2000. Abstracts pp 95–96

  30. Leppert W (2001) Analgesic efficacy and side effects of oral tramadol and morphine administered orally in the treatment of cancer pain, Nowotwory 51(3):257–266

    Google Scholar 

  31. Leppert W, Łuczak J (1997) Assessment of analgesic efficacy and side-effects of tramadol and morphine administered orally in the treatment of cancer pain. Progress Palliat Care 5:3–4

    Google Scholar 

  32. Leppert W, Łuczak J (1998) Preliminary experience with the use of Tramal Long administered orally in the treatment of cancer pain. 11th Annual Scientific Meeting of the European Association for Cancer Education (EACE), 22–25 April, Warsaw, Poland. Abstract book, abstract SVI-PC3

  33. Leppert W, Łuczak J (2002) Rola tramadolu w leczeniu bólu nowotworowego. Pol Med Paliatywna 1(2):93–105

    Google Scholar 

  34. Leppert W, Luczak J, Wozniak SP (2001) Analgesic efficacy and side effects of oral tramadol and morphine in the treatment of cancer pain—retrospective study (abstract). 13th MASCC/ISOO International Symposium Copenhagen, Denmark, 14–16 June 2001. Support Care Cancer 9(4):310

    Google Scholar 

  35. Leppert W, Luczak J, Oliver D (2002) Tramadol and cancer pain, Eur J Palliat Care 9(2):49–51

    Google Scholar 

  36. Leppert W, Łuczak J, Milecki P, et al (2003) The role of tramadol in the treatment of cancer pain in Poland (abstract A-44). 15th MASCC/ISOO International Symposium, Berlin, Germany, 18–21 June 2003. Support Care Cancer 11(6):398

    Google Scholar 

  37. Liao S, Hill JF, Nayak RK (1992) Pharmacokinetics of tramadol following single and multiple oral doses in man (abstract PPDM 8206). Pharm Res [Suppl] 9:308

    Google Scholar 

  38. Lintz W (1990) Pharmacokinetics of tramadol and its metabolite M1 in patients with impaired renal function and in those undergoing hemodialysis or other artificial blood purification processes (data on file). Report no. FO-PK 218. Grnenthal, Aachen, Germany

  39. Lintz W, Erlacin S, Francus E, et al (1981) Biotransformation of tramadol in man and animals. Arzneimittelforschung 31:1932–1943

    CAS  PubMed  Google Scholar 

  40. Lintz W, Barth H, Osterloh G, Schmidt-Böthelt E (1986) Bioavailability of enteral tramadol formulations. Arzneimittelforschung 36:1278–1283

    CAS  PubMed  Google Scholar 

  41. Łuczak J, Kotlińska A, Andrzejewska J, Leppert W, et al (1994) The use of tramadol in the treatment of cancer pain (abstract). Third Congress of the European Association for Palliative Care. J Palliat Care 13:96

    Google Scholar 

  42. Łuczak J, Kotlińska A, Leppert W, et al (1994) Zastosowanie tramadolu (Tramalu) w zwalczaniu bólu nowotworowego. Nowotwory 44:317–323

    Google Scholar 

  43. Łuczak J, Gorzelińska L, Ramlau R, Wojtukiewicz M, Koralewski P, Krzakowski M, Załuski J (2002) Ocena efektywności i bezpieczeństwa stosowania TTS fentanylu bezpośrednio po tramadolu, u pacjentów z bólem pochodzenia nowotworowego (na podstawie badania FEN-POL-2), Nowotwory J Oncol 52:216–220

    Google Scholar 

  44. Matthiesen T, Wöhrmann T, Coogan TP, Uragg H (1995) The experimental toxicology of tramadol: an overview, Toxicol Lett 98:63–71

    Google Scholar 

  45. Memiş D, Turan A, Karamanlioğlu B, Kaya G, Pamukçu Z (2002) The prevention of propofol injection pain by tramadol or ondansetron, Eur J Anaesth 19:47–51

    Google Scholar 

  46. Murphy DB, Sutton A, Prescott LF, Murphy MB (1997) A comparison of the effects of tramadol and morphine on gastric emptying in man, Anaesthesia 52:1212–1229

    Google Scholar 

  47. Nossol S, Schwarzbold M, Stadler T (1998) Treatment of pain with sustained-release tramadol 100, 150, 200 mg: results of a post-marketing surveillance study. Int J Clin Pract 52:115–121

    CAS  PubMed  Google Scholar 

  48. Okulicz-Kozaryn I, Mikołajczak P, Kamińska E, Szczawińska K, Leppert W, Łuczak J, et al (2001) Interakcja tramadolu z lekami wspomagającymi stosowanymi w leczeniu bólu w zaawansowanej chorobie nowotworowej–badania eksperymentalne, XVIII Naukowy Zjazd Polskiego Towarzystwa Farmaceutycznego Farmacja w XXI wieku, Poznań. Abstracts, p 380

  49. Osipova NA, Novikov GA, Beresnev VA, et al (1991) Analgesic effect of tramadol in cancer patients with chronic pain: a comparison with prolonged-action morphine sulphate. Cur Ther Res 50:812–821

    Google Scholar 

  50. Osipova N, Chissov V, Novikov G, et al (1994) Tramadol and buprenorphine: an alternative pharmacotherapy of chronic cancer pain. Proceedings of the XVI International Cancer Congress, New Delhi, India, 30 October to 5 November. Monduzzi Editore, International Proceedings Division, pp 2935–2939

    Google Scholar 

  51. Paar WD, Frankus P, Deugler HJ (1992) The metabolism of tramadol by human liver microsomes. Clin Invest 70:708–710

    CAS  Google Scholar 

  52. Paar WD, Poche S, Gerloff J, Dengler HJ (1997) Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadol. Eur J Clin Pharmacol 53:235–239

    Article  CAS  PubMed  Google Scholar 

  53. Pang WW, Wu HS, Lin CH, Chang DP, Huang MH (2002) Metoclopramide decreases emesis but increases sedation in tramadol patient-controlled analgesia. Can J Anesth 49:1029–1033

    Google Scholar 

  54. Petrone D, Kamin M, Olson W (1999) Slowing the titration rate of tramadol HCl reduces the incidence of discontinuation due to nausea and/or vomiting: a double-blind randomized trial. J Clin Pharm Ther 24:115–123

    Article  CAS  PubMed  Google Scholar 

  55. Petzke F, Radbruch L, Sabatowski R, Karthouse M, Mertens A (2000) Slow-release tramadol for treatment of chronic malignant pain—an open multicenter trial, Support Care Cancer 9:48–54

    Google Scholar 

  56. Płotkowiak Z, Popielarz-Brzezińska M, Andrzejewska J, Leppert W, Łuczak J (1996) Badania analityczne chlorowodorku tramadolu i jego mieszanin z lekami wspomagającymi. Biul Inst Leków 40(3):3–10

    Google Scholar 

  57. Poulsen L, Arendt-Nielsen L, Brøsen K, Sindrup SH (1996) The hypoalgesic effect of tramadol in relation to CYP2D6. Clin Pharmacol Ther 60:636–644

    CAS  PubMed  Google Scholar 

  58. Preston KL, Jasinski DR, Testa M (1991) Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend 27:7–17

    Article  CAS  PubMed  Google Scholar 

  59. Raffa RB, Friderichs E (1996) The basic science aspect of tramadol hydrochloride. Pain Rev 3:249–271

    CAS  Google Scholar 

  60. Raffa RB, Friderichs E, Reimann W, et al (1992) Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an “atypical” opioid analgesic. J Pharmacol Exp Ther 260:275–285

    CAS  PubMed  Google Scholar 

  61. Raffa RB, Friderichs E, Reimann W, et al (1993) Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 267:331–340

    CAS  PubMed  Google Scholar 

  62. Rodrigues N, Pereira ER (1989) Tramadol in cancer pain. Curr Ther Res 46:1142–1148

    Google Scholar 

  63. Rojas-Corrales MO, Ortega-Alvaro A, Gibert-Rahola J, Roca-Vinardell A, Micó JA (2000) Pindolol, a beta-adrenoceptor blocker/5-hydroxytryptamine1A/1B antagonist, enhances the analgesic effect of tramadol. Pain 88:119–124

    Article  CAS  PubMed  Google Scholar 

  64. Sauget D, Franco PS, Amaniou M, Mazere J, Dantoine T (2002) Possible syndrome sérotoninergique induit par l’association de tramadol à de la sertraline chez une femme agée. Thèrapie 57:309–310

    Google Scholar 

  65. Sevcik J, Nieber K, Driessen B, et al (1993) Effects of the central analgesic tramadol and its main metabolite, O-desmethyltramadol, on rat locus coeruleus neurons. Br J Pharmacol 110:169–176

    CAS  PubMed  Google Scholar 

  66. Shipton EA (2000) Tramadol—present and future. Anaesth Intensive Care 28:363–374

    CAS  PubMed  Google Scholar 

  67. Sindrup SH, Andersen GA, Madsen C, et al (1999) Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 83:85–90

    Article  CAS  PubMed  Google Scholar 

  68. Singlas E, Stahlberg HJ, Lintz W (1989) Pharmacokinetic study of tramadol and its metabolite M1 in patients with chronic hepatocellular insufficiency due to cirrhosis (data on file). Report no. FO-PK 288. Grunenthal, Aachen, Germany

  69. Stamer UM, Lehnen K, Höthker F, et al (2003) Impact of CYP2D6 genotype on postoperative tramadol analgesia. Pain 105:231–238

    Article  CAS  PubMed  Google Scholar 

  70. Staritz M, Poralla T, Manns M, Büschenfelde KHMZ (1986) Effect of modern analgesic drugs (tramadol, pentazocine, and buprenorphine) on the bile duct sphincter in man. Gut 27:567–569

    CAS  PubMed  Google Scholar 

  71. Säwe J, Dahlström B, Paalzow L, et al (1981) Morphine kinetics in cancer patients. Clin Pharmacol Ther 30:629–630

    PubMed  Google Scholar 

  72. Tawfik MO, Elborolossy K, Nasr F (1990) Tramadol hydrochloride in the relief of cancer pain. A double blind comparison against sustained release morphine. Pain 55:S377

    Google Scholar 

  73. Teppema LJ, Nieuwenhuijs D, Olievier CN, Dahan A (2003) Respiratory depression by tramadol in the cat. Anesthesiology 98:420–427

    Article  CAS  PubMed  Google Scholar 

  74. Twycross R, Wilcock A (2001) Symptom management in advanced cancer, 3rd edn. Radcliffe Medical Press, Oxford, pp 17–68

  75. Tzschentke TM, Bruckmann W, Friderichs E (2002) Lack of sensitisation during place conditioning in rats is consistent with the low abuse potential of tramadol. Neurosci Lett 329:25–28

    Article  CAS  PubMed  Google Scholar 

  76. Valle M, Garrido MJ, Pavón JM, Calvo R, Trocóniz IF (2000) Pharmacokinetic-pharmacodynamic modelling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-desmethyltramadol and (−)-O-desmethyltramadol, in rats. J Pharmacol Exp Ther 293:646–653

    CAS  PubMed  Google Scholar 

  77. Vickers M, O’Flaherty D, Szekely SM, et al (1992) Tramadol: pain relief by an opioid without depression of respiration. Anaesthesia 47:291–296

    CAS  PubMed  Google Scholar 

  78. Wilder-Smith CH, Bettiga A (1997) The analgesic tramadol has minimal effect on gastrointestinal motor function. Br J Clin Pharmacol 43:71–75

    CAS  PubMed  Google Scholar 

  79. Wilder-Smith CH, Schimke J, Osterwalder B, et al (1994) Oral tramadol, a mu-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain. Ann Oncol 5:141–146

    CAS  PubMed  Google Scholar 

  80. Wu WN, McKown LA, Liao S (2002) Metabolism of the analgesic drug ULTRAM (tramadol hydrochloride) in humans: API-MS and MS/MS characterization of metabolites, Xenobiotica 32:411–425

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chair and Department of Palliative Medicine, Poznan University of Medical Sciences, Osiedle Rusa 25 A, 61-245, Poznan, Poland

    Wojciech Leppert & Jacek Łuczak

Authors
  1. Wojciech Leppert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacek Łuczak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wojciech Leppert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leppert, W., Łuczak, J. The role of tramadol in cancer pain treatment—a review. Support Care Cancer 13, 5–17 (2005). https://doi.org/10.1007/s00520-004-0720-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-004-0720-4

Keywords

Search

Navigation